End of the clinical trial
Article 2 (26) of the CTR defines the end of a clinical trial as the last visit of the last subject in the last member state concerned, or at a later point in time as defined in the protocol.
- The enddate of the clinical trial in a MSc should be reported in CTIS within 15 days from the end of the clinical trial in relation to that MSc (art 37 CTR).
- The enddate of the clinical trial in all MSc in the EU as well as in all third countries should be reported in CTIS within 15 days from the end of the CT in the last of the MSc as well as in the last of the MSc and third countries in which the CT has been conducted.
See also Question 10.12 of the Q&A CTR.